Tamar L Mirensky

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications
    Tamar L Mirensky
    Department of Surgery, Yale New Haven Hospital, New Haven, CA 06520, USA
    Pediatr Res 63:559-68. 2008
  2. ncbi Outcomes of small bowel obstruction in patients with previous gynecologic malignancies
    Tamar L Mirensky
    Department of Surgery, Yale University School of Medicine, Office of Surgical Education, New Haven, CT 06520 8062, USA
    Am J Surg 203:472-9. 2012
  3. ncbi Tissue-engineered arterial grafts: long-term results after implantation in a small animal model
    Tamar L Mirensky
    Yale University School of Medicine, New Haven, CT 06510, USA
    J Pediatr Surg 44:1127-32; discussion 1132-3. 2009
  4. ncbi Tissue-engineered vascular grafts: does cell seeding matter?
    Tamar L Mirensky
    Yale New Haven Hospital, New Haven, CT 06510, USA Yale University School of Medicine, New Haven, CT 06510, USA
    J Pediatr Surg 45:1299-305. 2010
  5. ncbi Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model
    Jason D Roh
    Yale University School of Medicine, Interdepartmental Program in Vascular Biology and Therapeutics, New Haven, CT 06510, USA
    Biomaterials 29:1454-63. 2008
  6. ncbi Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
    Jason D Roh
    Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, CT 06510, USA
    Proc Natl Acad Sci U S A 107:4669-74. 2010

Detail Information

Publications6

  1. ncbi The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications
    Tamar L Mirensky
    Department of Surgery, Yale New Haven Hospital, New Haven, CA 06520, USA
    Pediatr Res 63:559-68. 2008
    ..The optimal scaffold, cell source, and conditioning parameters, however, still remain to be determined and are areas of active research...
  2. ncbi Outcomes of small bowel obstruction in patients with previous gynecologic malignancies
    Tamar L Mirensky
    Department of Surgery, Yale University School of Medicine, Office of Surgical Education, New Haven, CT 06520 8062, USA
    Am J Surg 203:472-9. 2012
    ..Features predictive of malignant small bowel obstructions among patients with previous gynecologic malignancies remain undetermined...
  3. ncbi Tissue-engineered arterial grafts: long-term results after implantation in a small animal model
    Tamar L Mirensky
    Yale University School of Medicine, New Haven, CT 06510, USA
    J Pediatr Surg 44:1127-32; discussion 1132-3. 2009
    ..Construction of an autologous neovessel using tissue engineering technology offers the potential to create an improved vascular conduit for use in pediatric vascular applications...
  4. ncbi Tissue-engineered vascular grafts: does cell seeding matter?
    Tamar L Mirensky
    Yale New Haven Hospital, New Haven, CT 06510, USA Yale University School of Medicine, New Haven, CT 06510, USA
    J Pediatr Surg 45:1299-305. 2010
    ..Little is known about the mechanisms involved in neovessel formation. We sought to define the role of seeded monocytes derived from bone marrow mononuclear cells (BM-MNCs) on neovessel formation...
  5. ncbi Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model
    Jason D Roh
    Yale University School of Medicine, Interdepartmental Program in Vascular Biology and Therapeutics, New Haven, CT 06510, USA
    Biomaterials 29:1454-63. 2008
    ..These results present the ability to create sub-1mm ID biodegradable tubular scaffolds that are functional as vascular grafts, and provide an experimental approach for the study of vascular tissue engineering using mouse models...
  6. ncbi Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
    Jason D Roh
    Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, CT 06510, USA
    Proc Natl Acad Sci U S A 107:4669-74. 2010
    ..These findings suggest TEVGs transform into functional neovessels via an inflammatory process of vascular remodeling...